Transforming the way we approach fatty liver disease isn't just about better diagnostics—it's about redefining patient care for a healthier tomorrow. 🌟 The shift from NAFLD to MAFLD in medical terminology not only marks a pivotal change in our understanding but also highlights the critical role of metabolic dysfunction in this condition, underlining the importance of personalized treatment strategies. At Arrow Dx, we're not just diagnosing fatty liver disease early; we're tailoring interventions to individual metabolic profiles, pioneering a future where care is as unique as each patient's DNA. 🧬💡 This terminology change from NAFLD to MAFLD is not just semantic; it signifies a deeper comprehension of the disease and a more focused approach to treatment. Dive deeper into how biotech innovations are paving the way for personalized medicine in our latest blog. Read now: https://lnkd.in/edAvAiqc #FattyLiverDisease #PersonalizedMedicine #ArrowDxInnovation
Arrow Dx’s Post
More Relevant Posts
-
Hey Sober Livers! Our parent company, Fatty Liver Foundation (FLF) has released their latest findings within this remarkable report, "The State of NAFLD/NASH Care In America," sharing patient survey results for 2023! From diagnosis to management, this survey hopes to shed light on insights about the patient journey. This report focuses on comparing last year's findings to this year's. Understanding where we are is the tool we need to fix liver health in the future! Thanks, FLF! View the results here: https://buff.ly/3uTsXG1.
-
-
📚 Unlock the Latest Insights on Paroxysmal Nocturnal Hemoglobinuria (PNH) Explore #PNH management nuances in a recent study from the Journal of Blood Medicine. Dive into advancements, highlighting C5 inhibitors like ravulizumab and their impact on hemolysis control and quality of life. Read the full article here: https://loom.ly/6L7pe0o 🗓 Join Dr. Monika Oliver on The Rounds for "CATCHing PNH - Identifying a Rare, Life-Threatening, Thrombotic Disease in Your Practice." Don't miss the chance to enhance your understanding of PNH!
-
-
Highly experienced drug development Business Developer underpinned by significant scientific knowledge
Transform a 2D CaCO2 permeability and absorption assay to a 3D more physiologically relevant model by the addition of a mucus layer. Take a read of this publication & reach out if interested!
New Publication! Check out our latest review on MUC2 mucin, exploring its polymerisation, post-secretory organisation and role in health and disease. Read the full article here: https://lnkd.in/eCtqRUJ9 The mucus barrier plays a crucial role in drug and nutrient absorption, and is often overlooked in pre-clinical R&D leading to costly failures. Get in touch to learn more about how we integrate mucus with gastrointestinal fluids and intestinal epithelia to accurately model the processes of human digestion and absorption in vitro. Congratulations to authors Kyle Stanforth, PhD Beth Adamson Maria Zakhour Niamh Robson!
-
-
Focus on personalized treatment approaches based on precision medicine to target autoimmune mechanisms in health conditions like Myasthenia Gravis. By understanding individual variations in immunoreactivities, symptoms, and disease severity, tailored strategies using innovative biological drugs can significantly improve patient outcomes. Consider exploring precision medicine options that specifically target key immunopathogenetic processes, such as B cell activation and NMJ damage, to enhance the effectiveness of treatment for autoimmune disorders. #PrecisionMedicine #AutoimmuneHealth #PersonalizedTreatment #BiologicalDrugs #PatientOutcomes BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X. Read more about this post here: https://lnkd.in/eRtfY4a4
-
Managing Director: Impact Shine Communications. Experienced Public Relations, Marketing Communications, Government Relations & IR Expert. Consultant Director: Influence Associates. WBF: Advisory Board Member.
Have a read of this highly informative peer review article.
New Publication! Check out our latest review on MUC2 mucin, exploring its polymerisation, post-secretory organisation and role in health and disease. Read the full article here: https://lnkd.in/eCtqRUJ9 The mucus barrier plays a crucial role in drug and nutrient absorption, and is often overlooked in pre-clinical R&D leading to costly failures. Get in touch to learn more about how we integrate mucus with gastrointestinal fluids and intestinal epithelia to accurately model the processes of human digestion and absorption in vitro. Congratulations to authors Kyle Stanforth, PhD Beth Adamson Maria Zakhour Niamh Robson!
-
-
💡 #ParticularInterestPaper 📝 Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis — Hemmers, et al. In this paper, the authors identified elevated levels of two chemokines in blood and kidney of chronic #kidney disease disease mouse models. Full text is available 👇 https://lnkd.in/dSgXVA4d #medicine #health #research #science
-
-
Latest figures out of the UK have found more than 6000 people are currently waiting for a kidney transplant, the highest level in 10 years, with experts concerned the number of people needing a kidney replacement will continue to rise due to increasing cases of type 2 diabetes. Proteomics International’s Managing Director Dr Richard Lipscombe highlighted how Australia can and should be learning lessons from UK’s kidney disease crisis in the December edition of Medical Forum Magazine, outlining the importance of developing diagnostic and prognostic tools to assist in the prevention and early diagnosis of this disease. Proteomics International are proud to play a role in the fight to reduce the negative impact of chronic kidney disease in type 2 diabetics. PromarkerD can predict disease onset up to four years in advance, enabling timely treatment before kidney function loss occurs. You can read Richard’s piece in full online at the Medical Forum Magazine - https://lnkd.in/g8cxtiVU You can read more about the latest figures out of the UK here - https://lnkd.in/gYiJUuJj #diabetes #kidneyhealth #Type2Diabetes #DiabeticKidneyDisease #PromarkerD #DiagnosticInnovation #prognostics #PIQ #EarlyDiseaseDetection #DiabetesManagement
-
🧬 Discover at INASL 2024 from August 7-10 to explore our poster presentation titled "One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population" using the OWLiver test. This innovative approach aims to improve the accuracy and ease of diagnosing these conditions, offering significant benefits for patient care and management. Our test demonstrates high sensitivity (86.1%) and positive predictive value (85.3%) for detecting MASH. The OWLiver Panel shows reliable accuracy in identifying MASH and significant fibrosis among high-risk individuals. This advancement in non-invasive diagnostics can revolutionize how we approach liver health and patient care.🔬 🗣️ Don't miss this opportunity to learn more about how our work can impact liver health and the future of medical diagnostics during the oral presentation of the poster on the Session - Special Interest Group (SIG) – MASLD the 9th August from 8:00 AM – 8.50 AM in Hall – 1. #INASL2024 #LiverHealth #Metabolomics #MedicalInnovation #Healthcare
-
-
🚀 Another Ren Bioscience Advancement! 🚀 We're excited to share that new data demonstrates a meaningful effect with oral dosing of Ren-101, showing a clear relationship between dose and therapeutic effect in the retina. This brings us another step closer to a breakthrough treatment for retinal diseases. If you know someone who has been impacted by retinal disease, please share this post to help us spread hope and drive innovation in retinal health. #RenBioscience #ClinicalResearch #VisionCare #RetinalHealth #Innovation
-
-
🔴 Recognizing World Thalassemia Day - Enhancing Care With Medical Technology 🔴 Yesterday marked World Thalassemia Day, a vital occasion to raise awareness and reflect on the impact of this genetic blood disorder. At Three Stars Medical Supplies, we stand committed to enhancing the lives of thalassemia patients through advanced life-saving medical technologies accessible and affordable globally. Our role in distributing state-of-the-art-medical devices - ranging from sophisticated blood analyzers, to efficient infusion systems-is more than a business commitment; it's designed to improve the quality of life for those managing this challenging genetic disorder. On this significant day, we celebrate our role as we continue our efforts, we dedicating in improving patient outcomes and easing the burden of thalassemia through innovation in healthcare technology. Let's keep pushing forward, making each day better for those affected by thalassemia. 🌏 💉 #WorldThalassemiaDay #Thalassemia #threestars #medicaldevices #healthcareinnovation #PatientCare #FightThalassemiaTogether
-
